Expertise in
11
conditions

Satoshi Yamaguchi

Chiba, JP 
Expertise in
11
conditions
Chiba, JP 
OverviewLocationsClinical Research

Overview

Satoshi Yamaguchi practices in Chiba, Japan. Yamaguchi is highly rated in 11 conditions, according to our data. Their top areas of expertise are Cervical Cancer, Osteoarthritis, Bunions, Hysterectomy, and Osteotomy.

Their clinical research consists of co-authoring 519 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Locations

Chiba, Japan
Other Locations
Osaka, Japan
Tokyo, Japan
Yokohama, 2360027, Japan
Kagoshima, Japan
Suita, 5650871, Japan
Ibaraki, 5670047, Japan
Akashi, Japan
Setagaya, 1568506, Japan
Asahikawa, Japan
Japan
Chuo, 2608670, Japan
Okayama, Japan
Okinawa, Japan
Nagoya, 4668550, Japan
Yushima, 1138510, Japan
Kanagawa, Japan
Chuo, Japan
Toyota Central R&D Labs, Inc, 1-1, Yokomichi, Nagakute, 4801192, Japan
Hongo, 1138656, Japan
Sapporo, Japan
Meguro, 1538904, Japan
Kawaguchi, 3510198, Japan
Togane, Japan
Kyoto, 6158510, Japan
Morioka, Japan
Tohoku, Japan
Sagamihara, Japan
Chiyoda, 1010062, Japan
Kodaira, 1878553, Japan
Itabashi, 1738605, Japan
Nagareyama, 2700174, Japan
Chikushino-shi, Japan
Furano, Japan
Fukuoka, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Open-Label, Phase 3 Trial of Tisotumab Vedotin vs Investigator's Choice Chemotherapy in Second- or Third-Line Recurrent or Metastatic Cervical Cancer
A Randomized, Open-Label, Phase 3 Trial of Tisotumab Vedotin vs Investigator's Choice Chemotherapy in Second- or Third-Line Recurrent or Metastatic Cervical Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 15, 2025
Intervention Type: Drug
Study Drugs: Tisotumab Vedotin, Topotecan, Vinorelbine, Gemcitabine, Irinotecan, Pemetrexed
Study Phase: Phase 3

519 Total Publications

Comparisons of optical characteristics between 3D printed dental resins and resin composites.
Comparisons of optical characteristics between 3D printed dental resins and resin composites.
Journal: American journal of dentistry
Published: November 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Yamaguchi's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 77 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile